Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Steroid-Refractory/Dependent Chronic GVHD
NCT00388362Phase 2Completed
- Sponsor
- Stanford University
- Start
- Nov 2005
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in chronic graft-versus-host disease (cGVHD), sponsored by Stanford University. Started Nov 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00388362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388362.